Paterna BioSciences, a biotech startup in Salt Lake City, UT, raised $6 million in seed funding to advance innovative treatments for male infertility.
- Funding Round: Raised $6 million in seed funding to drive its mission led by SpringTide Ventures, with contributions from e184, Utah Innovation Fund, Freya Ventures, Divergent Capital, Seaside Ventures, and angel investors.
- Funding Purpose: Supports preclinical work, team expansion, and infrastructure to advance IVS toward commercial readiness.
- Innovative Approach: Paterna is partnering with IVF clinics to integrate IVS, helping men proactively improve their reproductive health.
- Looking Ahead: Paterna’s goal is to empower men with more fertility options, creating a holistic approach to reproductive health.
Paterna BioSciences is on track to reshape fertility care with groundbreaking solutions for male infertility.
